Search Results - Guido Dalbagni
- Showing 1 - 20 results of 48
- Go to Next Page
-
1
-
2
-
3
-
4
-
5
The impact of smoking on pathologic response to neoadjuvant cisplatin-based chemotherapy in patients with muscle-invasive bladder cancer by Philip H., Kim, Matthew, Kent, Philip, Zhao, John P., Sfakianos, Dean F., Bajorin, Bernard H., Bochner, Guido, Dalbagni
Published 2013Text -
6
Impact of renal impairment on eligibility for adjuvant cisplatin‐based chemotherapy in patients with urothelial carcinoma of the bladder by Atreya Dash, Matthew D. Galsky, Andrew J. Vickers, Angel M. Serio, Theresa M. Koppie, Guido Dalbagni, Bernard H. Bochner
Published 2006Artigo -
7
-
8
-
9
Renal Function and Oncologic Outcomes of Parenchymal Sparing Ureteral Resection Versus Radical Nephroureterectomy for Upper Tract Urothelial Carcinoma by Jonathan Silberstein, Nicholas Power, Caroline Savage, Tatum Tarin, Ricardo L. Favaretto, Daniel Su, Matthew Kaag, Harry W. Herr, Guido Dalbagni
Published 2011Artigo -
10
Combining imaging and ureteroscopy variables in a preoperative multivariable model for prediction of muscle‐invasive and non‐organ confined disease in patients with upper tract uro... by Ricardo L. Favaretto, Shahrokh F. Shariat, Caroline Savage, Guilherme Godoy, Daher Chade, Matthew Kaag, Bernard H. Bochner, Jonathan Coleman, Guido Dalbagni
Published 2011Artigo -
11
Lymph Node–Positive Bladder Cancer Treated With Radical Cystectomy and Lymphadenectomy: Effect of the Level of Node Positivity by Tatum Tarin, Nicholas Power, Behfar Ehdaie, John P. Sfakianos, Jonathan Silberstein, Caroline Savage, Daniel D. Sjoberg, Guido Dalbagni, Bernard H. Bochner
Published 2012Artigo -
12
The Effect of Tumor Location on Prognosis in Patients Treated with Radical Nephroureterectomy at Memorial Sloan-Kettering Cancer Center by Ricardo L. Favaretto, Shahrokh F. Shariat, Daher Chade, Guilherme Godoy, Ari Adamy, Matthew Kaag, Bernard H. Bochner, Jonathan Coleman, Guido Dalbagni
Published 2010Artigo -
13
Age‐adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer by Theresa M. Koppie, Angel M. Serio, Andrew J. Vickers, Kinjal Vora, Guido Dalbagni, S. Machele Donat, Harry W. Herr, Bernard H. Bochner
Published 2008Artigo -
14
Cyclooxygenase-2 and Microsomal Prostaglandin E Synthase-1 Are Overexpressed in Squamous Cell Carcinoma of the Penis by Dragan Golijanin, Jianyou Tan, Agnieszka Kazior, Erik G. Cohen, Paul Russo, Guido Dalbagni, Karen J. Auborn, Kotha Subbaramaiah, Andrew J. Dannenberg
Published 2004Artigo -
15
-
16
-
17
Comparison Between Laparoscopic and Open Radical Nephroureterectomy in a Contemporary Group of Patients: Are Recurrence and Disease-Specific Survival Associated with Surgical Techn... by Ricardo L. Favaretto, Shahrokh F. Shariat, Daher C. Chade, Guilherme Godoy, Matthew Kaag, Angel M. Cronin, Bernard H. Bochner, Jonathan Coleman, Guido Dalbagni
Published 2010Artigo -
18
Phase II Trial of Intravesical Gemcitabine in Bacille Calmette-Guérin–Refractory Transitional Cell Carcinoma of the Bladder by Guido Dalbagni, Paul Russo, Bernard H. Bochner, Leah Ben‐Porat, Joel Sheinfeld, Pramod C. Sogani, S. Machele Donat, Harry W. Herr, Dean F. Bajorin
Published 2006Artigo -
19
-
20
The Impact of Plasmacytoid Variant Histology on the Survival of Patients with Urothelial Carcinoma of Bladder after Radical Cystectomy by Qiang Li, Melissa Assel, Nicole Benfante, Eugene J. Pietzak, Harry W. Herr, S. Machele Donat, K. Eugene, Timothy F. Donahue, Bernard H. Bochner, Guido Dalbagni
Published 2017Artigo
Search Tools:
Related Subjects
Medicine
Internal medicine
Cancer
Bladder cancer
Urology
Surgery
Biology
Cystectomy
Oncology
Cancer research
Chemotherapy
Carcinoma
General surgery
Lymph node
Paleontology
Confidence interval
Gene
Genetics
Hazard ratio
Pathology
Proportional hazards model
Cisplatin
Gemcitabine
Kidney
Nephrectomy
Stage (stratigraphy)
Urothelial carcinoma
Breast cancer
Cohort
Disease